S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer
Status:
Unknown status
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The primary goal of this phase II trial is to evaluate the response rate of combination
chemotherapy with S-1 and Irinotecan in patients with advanced gastric cancer as a first-line
therapy.